About Paul Hallenbeck
Paul Hallenbeck is an executive officer and director at Seneca Therapeutics.
Paul Hallenbeck first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Paul Hallenbeck in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Paul Hallenbeck works with at each company, as listed on that company's latest Form D.
Seneca Therapeutics, Inc. · Form D, Feb 7, 2025
